// App-Quantinova.ai

PR‐002 : Concurrent treatment of aplastic anaemia (AA)/paroxysmal nocturnal haemoglobinuria (PNH) syndrome with immunosuppressive therapy and eculizumab: a UK experience

Researchers

Presenter

  • M Griffin

Principal Investigators

  • A Kulasekararaj

  • S Gandhi

  • P Hillmen

  • T Munir

  • J Marsh

  • S Richards

  • L Arnold

  • N Benson-Quarm

  • K Pelton

  • K Riley

  • A Hill

Medical Centers

  • Hematology, Leeds Teaching Hospital

  • Haematological Medicine, Kings College Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Cyclosporine A

  • Eculizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved